Radiopharm Theranostics L... (RADX)
NASDAQ: RADX
· Real-Time Price · USD
5.21
0.04 (0.68%)
At close: Aug 19, 2025, 3:57 PM
5.41
3.94%
After-hours: Aug 19, 2025, 07:53 PM EDT
0.68% (1D)
| Bid | 4.15 |
| Market Cap | 6.71M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -12.22 |
| PE Ratio (ttm) | -0.43 |
| Forward PE | -1.03 |
| Analyst | Buy |
| Ask | 5.5 |
| Volume | 45,232 |
| Avg. Volume (20D) | 21,401 |
| Open | 5.08 |
| Previous Close | 5.17 |
| Day's Range | 4.80 - 5.50 |
| 52-Week Range | 3.50 - 50.82 |
| Beta | 0.81 |
About RADX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RADX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RADX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+4.9%
Radiopharm Theranostics shares are trading higher ...
Unlock content with
Pro Subscription
2 months ago
+11.18%
Radiopharm Theranostics shares are trading higher after the company announced preclinical data from studies with the Lu177-B7H3-monoclonal antibody RV01.